Therefore, the increased accumulation by MRP1 inhibitors should be considered when we use nitroimidazole-based PET imaging agents for diagnosing hypoxia not only in tumor tissues but also other pathological tissues. This evidence concerns the gene ABCC1 and neoplasm.